MarketPulse

misleading metrics

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Hagens Berman

Soleno Therapeutics Faces Securities Class Action Over VYKAT XR Safety Disclosures

Hagens Berman files securities class action against $SLNO alleging concealed safety risks and inflated metrics for hyperphagia drug VYKAT XR. Stock crashed 27% following August activist report and November earnings miss.
SLNOinvestor lossessecurities class action
The Motley FoolThe Motley Fool··Timothy Green

Chewy's Autoship Metric Masks True Recurring Revenue Composition

Chewy's 84% Autoship metric inflates recurring revenue perception; includes all purchases by subscription customers, not just automated renewals. Actual subscription revenue is lower.
CHWYrevenue growthoperating margins